| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 50.067 | 74.844 | 90.404 | 107.929 |
| Total Income - EUR | - | - | - | - | - | - | 50.068 | 74.910 | 90.408 | 108.038 |
| Total Expenses - EUR | - | - | - | - | - | - | 17.913 | 34.745 | 38.165 | 40.317 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 32.155 | 40.165 | 52.243 | 67.721 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 31.654 | 39.416 | 51.339 | 65.686 |
| Employees | - | - | - | - | - | - | 3 | 0 | 3 | 0 |
Check the financial reports for the company - Cabinet Medical Dr. Şalplahta Daniel S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 22.919 | 19.375 | 15.642 | 11.930 |
| Current Assets | - | - | - | - | - | - | 10.178 | 31.918 | 52.585 | 57.322 |
| Inventories | - | - | - | - | - | - | 709 | 784 | 925 | 0 |
| Receivables | - | - | - | - | - | - | 5.685 | 29.142 | 12.177 | 48.382 |
| Cash | - | - | - | - | - | - | 3.784 | 1.992 | 39.483 | 8.940 |
| Shareholders Funds | - | - | - | - | - | - | 31.694 | 39.465 | 65.552 | 65.738 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.403 | 11.828 | 2.675 | 3.514 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cabinet Medical Dr. Şalplahta Daniel S.r.l.